J’Onco Mentor Version 9.09 — BLADDER PRIMARY

Desktop version. Mobile app coming.

WHAT IS J’ONCO MENTOR?LUNGBREASTHEAD & NECKPROSTATEENDOMETRIUMLIVERADRENAL GLANDKIDNEYTHYROIDBLADDERCOLON & RECTUMMELANOMA OF SKINPANCREASSTOMACHCNSHEMATOPOIETIC DISORDERSTOP CANCER SITESSTORE MANUALRADIATION GUIDESTATE REPORTABILITYICD-10-CM / SECONDARY DXODS RESOURCES

DIAGNOSIS YEAR

Select the diagnosis year first. J’Onco Mentor uses it to establish the standards cycle and to drive year-sensitive routing in this module.

SEER manual—
NAACCR cycle—
Staging context—
Standards statusSelect year
No diagnosis year selected. Year-dependent schema, staging, SSDI, grade, surgery, and manual guidance should not be assumed.

INTERACTIVE BLADDER SITE SELECTOR

Realistic cutaway anatomy of urinary bladder with ureteral orifices, trigone, bladder neck and surrounding wall

BLADDER TOPOGRAPHY

ALL BLADDER SUBSITES — C67.0 THROUGH C67.9

Every coded bladder subsite is displayed below. C67.8 (overlapping lesion) and C67.9 (bladder, NOS) are coding categories rather than discrete anatomic locations, so they are available here and in the dropdown but are not shown as anatomy hotspots.

Use the anatomy, full topography dropdown, or quick-select buttons. The dropdown provides the complete C67.0–C67.9 bladder topography set, including sites that cannot be reliably shown on a single frontal cutaway.



Type a code or name, or use the dropdown below. Both controls stay synchronized.


SELECTED BLADDER SITE(S)

None selected.

CALCULATED PRIMARY SITE

—

No bladder site selected.

Topography rule: Selecting an additional bladder subsite does not automatically change the primary topography. If the site of origin is documented, retain the documented primary C67.x code. Use C67.8 only when one tumor overlaps bladder subsites and the point of origin cannot be determined.

HISTOLOGY / SCHEMA CONTEXT

Type a code or name, or use the dropdown below. Both controls stay synchronized.

This mirrors the Histology field in the Site / Anatomy section. Select in either location; both remain synchronized.

SCHEMA ROUTING

—

Select site and histology to identify schema context.

Urinary histology reminder: Noninvasive papillary urothelial carcinoma and flat urothelial carcinoma in situ are not equivalent. Code the histology documented by the pathologist and apply the current Urinary Solid Tumor Rules.

MULTIPLE PRIMARY RULES — URINARY

Multiple bladder tumors

Multiple invasive urothelial carcinomas within the bladder may be abstracted as a single primary under the current urinary rules when applicable.

Multiple urinary organs

Urothelial tumors can involve bladder, ureter, renal pelvis or other urinary sites. Apply the current Urinary M rules rather than counting organs alone.

Overlap

A single tumor overlapping bladder subsites is coded C67.8 when the point of origin cannot be determined. Current urinary rules contain special instructions for urothelial CIS involving bladder and ureter.

Current-rule reminder: The Solid Tumor Rules are periodically updated and may apply retrospectively to 2018+ cases. Verify the current Urinary rule set for the diagnosis being abstracted.

AJCC STAGING

PATHOLOGIC STAGING CRITERIA — URINARY BLADDER

Qualifying evidence: TURBT can establish a pathological invasion category based on tissue actually present, including muscularis propria when sampled. Cystectomy permits broader assessment of local extent. Do not infer uninvolved layers or pN0 from unsampled tissues or nodes.

pT / pN: Assign only categories supported by the actual pathological evidence and the site-specific AJCC rules. A diagnosis-confirming biopsy does not automatically establish a pathological primary tumor category.

pM: Pathologically proven distant metastasis may support pM1 where the chapter permits; AJCC does not use pM0.

Treatment sequence: Distinguish initial pathological classification (pTNM) from post-neoadjuvant classification (ypTNM). Confirm eligibility, histology, staging chapter and diagnosis-year edition before finalizing.

Source / verification: AJCC · SEER tools and manuals. Educational overview only; verify exact chapter-specific criteria in the licensed AJCC manual.

Urinary Bladder AJCC staging schema / TNM context

Use the T, N and M controls and site-specific factors below. Verify final AJCC ID, TNM edition and stage group in the approved AJCC/SEER staging system for the diagnosis year.




AJCC 8 RESULT

T—
N—
M—
Stage Group—

Select T, N and M.

TURBT caution: Do not automatically subdivide T2 into T2a/T2b from a TURBT alone. Use the appropriate clinical/pathologic time frame and the AJCC/SEER criteria applicable to the documentation.

REGIONAL LYMPH NODES

N1

Single true-pelvis node

Perivesical, obturator, internal iliac, external iliac, or sacral.

N2

Multiple true-pelvis nodes

Multiple regional nodes within the true pelvis.

N3

Common iliac nodes

Metastasis to common iliac lymph nodes.

Distant nodes: Nodes beyond the common iliacs are distant for AJCC M classification and can qualify as M1a when distant disease is limited to lymph nodes.

EOD / SUMMARY STAGE

SEER*RSA Bladder Schema

Bladder topographies C67.0–C67.9 with applicable bladder histologies use the Bladder EOD schema. Exact EOD Primary Tumor, Regional Nodes and Mets codes should be assigned from the diagnosis-year SEER*RSA schema.

Summary Stage framework

In situ — noninvasive flat/papillary disease as applicable.
Localized — confined to bladder.
Regional — direct extension and/or regional nodes.
Distant — distant nodes or organs.

Do not infer EOD numeric codes from AJCC labels alone. Use the current SEER*RSA Bladder schema because TURBT versus cystectomy documentation can affect how depth of invasion is coded.

GRADE — BLADDER


GRADE GUIDANCE

Select histology to display the appropriate grade family.

For urothelial cancers, current SEER grade guidance prioritizes Low/High. If only G1–G3 is documented for urothelial carcinoma, code unknown as instructed. Adenocarcinoma and squamous cell carcinoma use numeric grades 1–3/9.

TURBT: qualifies for clinical grade; it does not qualify as the definitive resection required for pathological grade. Partial/complete cystectomy is required for the bladder pathological-grade context.

SURGERY OF PRIMARY SITE — BLADDER

SURGERY CODE

—

No surgery selected.

A100–A160

Local destruction / intravesical

Includes fulguration, laser, intravesical therapy, and BCG/immunotherapy categories as defined by the surgery code table.

A270

TURBT / excisional biopsy

SEER specifically directs TURB/TURBT to A270.

A300

Partial cystectomy

A500

Simple / total / complete cystectomy

A600–A640

Cystectomy with reconstruction

Includes ileal conduit and continent/orthotopic diversion variants.

A700–A740

Pelvic exenteration family

A710 includes radical cystectomy with anterior exenteration; use A710 for cystoprostatectomy or cystectomy with hysterectomy per SEER note.

COMMON METASTATIC SITES — BLADDER

Common distant sites include bone, liver and lung; SEER bladder training also identifies brain as a recognized metastatic site.

COMMON

Bone

COMMON

Liver

COMMON

Lung

RECOGNIZED

Brain

Registrar reminder: Regional pelvic nodes are not distant metastases. Common iliac nodes are regional (N3); nodes beyond the common iliacs are distant.

SOURCES

2027 standards cycle: Use the 2027 SEER Program Coding and Staging Manual, Solid Tumor Rules 2027, STORE 2027, NAACCR v27 resources, Summary Stage v3.4, and the current diagnosis-year SEER*RSA/EOD schema as applicable. Historical cases may require prior-year instructions.